ImmunogenX Acquired by First Wave BioPharma
2 minute read | April.10.2024
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.
News & Client Results
Combatting Rare Pediatric Disease: Ipsen to Sell Priority Review Voucher
2 minute read | October.10.2024
Ipsen has agreed to sell its rare pediatric disease priority review voucher to a large global pharmaceutical company for $158 million.
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. to Combine to Form Dogwood Therapeutics, Inc.
2 minute read | October.07.2024
Virios Therapeutics plans to combine with Wex Pharmaceuticals in an all-stock transaction to form a combined company called Dogwood Therapeutics.
Managing IP Highlights Irena Royzman’s IP Work for the Life Science and Tech Sectors
1 minute read | September.10.2024
Managing IP features Orrick IP partner Irena Royzman for her impact in shaping patent protections for life sciences and tech clients.
Laser Systems in Health Care: Afinum Investments Form MedTech Laser Group
1 minute read | July.31.2024
European investment firm Afinum has formed MedTech Laser Group through its investment in German company A.R.C. Laser and Israeli company G.N.S. ...
Orrick Grows Life Sciences & HealthTech Platform with 7-Lawyer FDA and Healthcare Regulatory Team
6 minute read | July.11.2024
Welcome to a trio of leading FDA and healthcare regulatory advisors.
Tech and Life Sciences Companies Urge USPTO to Abandon Proposed Patent Rule
2 minute read | July.10.2024
Orrick intellectual property team behind tech and life sciences effort to reverse proposed U.S. Patent and Trademark Office rule
Amicus Effort Backs Tech and Life Sciences Innovators in U.S. Supreme Court Case
1 minute read | June.25.2024
In case of major importance to the tech and life sciences sectors, an Orrick team urges U.S. Supreme Court to reverse patent decision in Cellect.
Federal Circuit Urged in Amicus to Protect Patent Rights of Biotech Innovators
1 minute read | May.15.2024
Orrick life sciences team files amicus brief in major appellate case involving patent rights of biotechnology industry.
Advancing Effective Mental Healthcare: Grow Therapy Raises $88 Million
2 minute read | April.11.2024
Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88 million funding round.
‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc.
2 minute read | April.10.2024
Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.
Events
Events
2023 Berkeley Center for Law & Technology (BCLT) Privacy Law Forum: Life Sciences
Orrick's Shannon Yavorsky will be co-leading a session at the BCLT Privacy Law Forum for Life Sciences exploring issues surrounding life sciences, technology and privacy legal regimes.
Events
New York Intellectual Property Law Association’s (NYIPLA) Patent Seminar
Orrick Intellectual Property Partner, Irena Royzman, will be speaking at NYIPLA’s One-Day Patent CLE Seminar on November 7, 2024.
Events
Women in AI and Healthcare Panel
Please join Team Orrick and the Women’s General Counsel Network (WGCN) for an insightful discussion centered around emerging trends in AI and healthcare. We'll explore how key topics impact women and uncover valuable insights through dynamic conversations. Following the program, we invite you to ...
Events
Fortifying Healthcare IT: Strategies to Protect Your Organization from Rising Class Action Lawsuits
Aravind Swaminathan will co-lead a discussion on the origin of the private right of action for privacy breaches, the effects, and where it’s going.
Events
New Jersey Intellectual Property Law Association (NJIPLA) Patent Litigation Seminar 2024
On Thursday, May 16, 2024, Intellectual Property partner Irena Royzman will lead a presentation titled "Mandatory Clinical Trial Disclosures as Prior Art" at NJIPLA's 2024 Patent Litigation Seminar.
Events
Reception during the 2024 JP Morgan Healthcare Conference
In collaboration with Cathay Innovation and Horizon Technology Finance, we are co-hosting a networking reception to kick off the 2024 JP Morgan Healthcare Conference. From disruptive startups to investors, pharmaceutical leaders, healthcare innovators, payors and providers, join fellow leaders in ...